Comment identifier les plantes de la famille Boraginaceae ?

Les Boraginaceae se caractérisent par des fleurs en grappes et des feuilles alternées.

Quels tests pour évaluer l'efficacité des Boraginaceae ?

Des études cliniques et des tests in vitro sont utilisés pour évaluer leur efficacité.

Y a-t-il des critères spécifiques pour le diagnostic ?

Le diagnostic repose sur l'identification botanique et l'analyse des propriétés médicinales.

Comment distinguer les Boraginaceae des autres familles ?

L'observation des caractéristiques florales et des feuilles aide à la distinction.

Quels outils pour identifier les Boraginaceae ?

Des guides botaniques et des applications de reconnaissance de plantes sont utiles.

Quels symptômes sont associés à l'utilisation des Boraginaceae ?

Des réactions allergiques, des troubles gastro-intestinaux ou des effets secondaires peuvent survenir.

Les Boraginaceae provoquent-elles des effets indésirables ?

Oui, certaines espèces peuvent causer des effets indésirables comme des nausées.

Quels symptômes d'intoxication peuvent survenir ?

Des symptômes tels que des vomissements, des douleurs abdominales peuvent apparaître.

Comment reconnaître une réaction allergique aux Boraginaceae ?

Des démangeaisons, éruptions cutanées ou œdème peuvent indiquer une allergie.

Les Boraginaceae peuvent-elles causer des troubles respiratoires ?

Oui, des troubles respiratoires peuvent survenir en cas d'allergie ou d'intoxication.

Comment éviter les effets indésirables des Boraginaceae ?

Il est conseillé de commencer par de faibles doses et de surveiller les réactions.

Quelles précautions prendre avant d'utiliser des Boraginaceae ?

Consulter un professionnel de santé avant utilisation, surtout en cas de maladies préexistantes.

Les Boraginaceae peuvent-elles interagir avec d'autres médicaments ?

Oui, elles peuvent interagir avec certains médicaments, il est donc important de vérifier.

Comment stocker les préparations à base de Boraginaceae ?

Conserver dans un endroit frais et sec, à l'abri de la lumière pour préserver l'efficacité.

Y a-t-il des recommandations pour l'utilisation des Boraginaceae ?

Suivre les recommandations d'un professionnel de santé et respecter les dosages conseillés.

Comment les Boraginaceae sont-elles utilisées en médecine ?

Elles sont utilisées pour traiter des inflammations, des douleurs et des troubles cutanés.

Quels remèdes à base de Boraginaceae existent ?

Des infusions, des pommades et des extraits sont couramment utilisés.

Les Boraginaceae sont-elles efficaces contre l'inflammation ?

Certaines études montrent qu'elles peuvent réduire l'inflammation et la douleur.

Comment préparer un remède à base de Boraginaceae ?

Les feuilles peuvent être infusées ou utilisées en cataplasme pour des applications topiques.

Y a-t-il des contre-indications pour les traitements à base de Boraginaceae ?

Oui, certaines personnes, comme les femmes enceintes, doivent éviter leur utilisation.

Quelles complications peuvent survenir avec les Boraginaceae ?

Des complications comme des allergies sévères ou des troubles gastro-intestinaux peuvent survenir.

Les Boraginaceae peuvent-elles causer des problèmes hépatiques ?

Certaines espèces contiennent des composés toxiques pouvant affecter le foie.

Comment gérer une réaction allergique aux Boraginaceae ?

Cesser l'utilisation immédiatement et consulter un médecin si les symptômes persistent.

Y a-t-il des risques d'intoxication avec les Boraginaceae ?

Oui, une consommation excessive peut entraîner des symptômes d'intoxication.

Les Boraginaceae peuvent-elles aggraver des maladies existantes ?

Elles peuvent aggraver certaines conditions, comme les maladies hépatiques ou rénales.

Qui est à risque d'allergies aux Boraginaceae ?

Les personnes ayant des antécédents d'allergies aux plantes sont plus à risque.

Les femmes enceintes doivent-elles éviter les Boraginaceae ?

Oui, il est recommandé qu'elles évitent leur utilisation en raison de risques potentiels.

Quels facteurs augmentent le risque d'intoxication ?

Une consommation excessive ou l'utilisation de préparations non contrôlées augmentent le risque.

Les personnes âgées sont-elles plus vulnérables ?

Oui, elles peuvent être plus sensibles aux effets indésirables des Boraginaceae.

Y a-t-il des risques pour les personnes atteintes de maladies chroniques ?

Oui, les personnes atteintes de maladies chroniques doivent être prudentes avec leur utilisation.

Boraginaceae - Informations médicales vérifiées

Laxatives are Associated with Poorer Polysomnography-derived Sleep Quality.

07 2023

DOI: 10.1017/cjn.2022.264 PMID: 35723037

To characterize 1) the relationship between laxative use and objective sleep metrics, and 2) the relationship between laxative use and self-reported insomnia symptoms in a convenience sample of middle... We cross-sectionally analyzed first-night diagnostic in-laboratory polysomnography data for 2946 patients over the age of 40 (mean age 60.5 years; 48.3% male). Laxative use and medical comorbidities w... After adjusting for age, sex, body mass index, total recording time, and relevant comorbidities, laxative users had a 7.1% lower sleep efficiency (... Laxative use is associated with impairments in objective sleep continuity. Patients using laxatives were also at greater odds of reporting insomnia symptoms....

Aged Middle Aged Humans Male Female +6 autres

Adherence to coprescribing of laxatives with opioids and associated characteristics in general practices in the Netherlands.

05 12 2022

DOI: 10.1186/s12875-022-01911-8 PMID: 36464672

Guidelines recommend to prescribe a laxative with an opioid to prevent constipation. We aimed to determine the adherence by general practitioners (GPs) to this recommendation and to explore which GP- ... The recommendation was measured in 195 general practices. The median proportion of first opioid prescriptions prescribed together with a laxative in these practices was 54% (practice range 18-88%). No... There was room for improvement in following the guideline on laxative prescribing in opioid use. A main reason seemed to be that the patient refuses a laxative. Improvement measures should therefore f...

Humans Laxatives Analgesics, Opioid Netherlands General Practice +1 autres

The relation between second-generation antipsychotics and laxative use in elderly patients with schizophrenia.

Sep 2022

DOI: 10.1111/psyg.12875 PMID: 35810468

We aimed to investigate factors associated with concomitant laxative use among elderly patients with schizophrenia, discharged on second-generation antipsychotics (SGAs), from two large public psychia... Elderly patients with schizophrenia who were discharged between 2006 and 2019 and received SGA monotherapy at discharge were included in the analysis. Multivariate logistic regression was used to iden... A total of 2591 elderly patients with schizophrenia were discharged during the study period, and 1727 of 2591 patients who met the inclusion criteria were included for analysis. Of these 1727 patients... Laxative use is common in elderly schizophrenia patients treated with SGAs. In cases of clinically significant constipation, switching to an SGA with a lower risk for constipation, or discontinuing th...

Aged Antipsychotic Agents Benzodiazepines Constipation Female +7 autres

Association Between Regular Laxative Use and Incident Dementia in UK Biobank Participants.

18 04 2023

DOI: 10.1212/WNL.0000000000207081 PMID: 36813729

The use of over-the-counter laxatives is common in the general population. The microbiome-gut-brain axis hypothesis suggests that the use of laxatives could be associated with dementia. We aimed to ex... This prospective cohort study was based on UK Biobank participants aged 40-69 years without a history of dementia. Regular use of laxatives was defined as self-reported use in most days of the week fo... Among the 502,229 participants with a mean age of 56.5 (SD 8.1) years at baseline, 273,251 (54.4%) were female, and 18,235 (3.6%) reported regular use of laxatives. Over a mean follow-up of 9.8 years,... Regular use of laxatives was associated with a higher risk of all-cause dementia, particularly in those who used multiple laxative types or osmotic laxative....

Humans Female Middle Aged Male Laxatives +6 autres

A sensitive and quantitative immunochromatographic assay for simultaneous detection of three stimulant laxatives in slimming food.

01 Jan 2023

DOI: 10.1016/j.foodchem.2022.133861 PMID: 35973297

Bisacodyl, sodium picosulfate and their metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM) are clinically used to treat constipation. In this study, with the rational hapten design, a broad-spe...

Antibodies, Monoclonal Bisacodyl Chromatography, Affinity Chromatography, Liquid Immunoassay +3 autres

Relation between laxative use and risk of major bleeding in patients with atrial fibrillation and heart failure.

Jul 2023

DOI: 10.1007/s00380-023-02249-6 PMID: 36799967

Constipation has been reported to increase the risk of cardiovascular mortality. Patients with atrial fibrillation (AF) and heart failure (HF) have more comorbidities and an increased bleeding risk. H...

Humans Laxatives Atrial Fibrillation Retrospective Studies Hemorrhage +4 autres

Influence of peritoneal dialysis catheter type on dislocations and laxative use: a retrospective observational study.

06 2022

DOI: 10.1007/s40620-022-01329-6 PMID: 35522428

There is currently no consensus regarding the optimal type of peritoneal dialysis (PD) catheter. Although few studies showed that weighted catheters result in lower complication rates and superior lon... We performed a single-center, retrospective, observational study in two renal units, comparing acute and chronic laxative therapy related to catheter drainage failure in a cohort of 74 PD patient,s di... Laxative use was significantly more common among patients in the non-weighted catheter group (acute: 30.3% vs. 9.8%, p = 0.03; chronic: 36.4% vs. 12.2%; p≤0.02). Furthermore, weighted catheters were s... Weighted self-locating catheters have lower drainage failure, thus reducing the need and burden of acute and chronic laxative use among PD patients....

Catheters, Indwelling Equipment Failure Humans Laxatives Peritoneal Dialysis +2 autres

Laxative-prescribing habits: a summative impact evaluation of a constipation programme implemented in two hospitals in New Zealand.

01 Dec 2023

PMID: 38033241

To evaluate the impact of a multifaceted intervention aimed at improving adherence to a list of preferred laxatives in two hospitals in New Zealand.... A constipation programme was developed at Capital & Coast District Health Board to improve adherence to safe and effective (preferred) laxatives over potentially dangerous and less effective (non-pref... Prior to the programme, there were 111,771 laxatives dispensed, the majority of which (62%) were non-preferred agents. Following the programme, there were 91,005 laxatives dispensed, the majority of w... Inpatient laxative prescribing habits require attention and are amenable to quality improvement initiatives. This may reduce waste, prevent harm and improve patient outcomes....

Adult Humans Laxatives Retrospective Studies New Zealand +2 autres

Fatal complication caused by laxative suppository agent on pediatric patient with hydrocephalus on ventriculo-peritoneal shunt: a case report.

06 2023

DOI: 10.1007/s00381-023-05874-8 PMID: 36763154

Laxative suppository agent is oftenly used for patient with constipation due to its effectiveness and rapid onset. However, beside the benefit of the drugs, it could cause several side effects which c... An 11 years old boy admitted with general weakness, low nutrition intake, and constipation for 4 days. Patient had a history of VP shunt surgery at half months old due to congenital hydrocephalus. Abd... The pathophysiology of this complication is related with elevated intraabdominal pressure that caused abdominal compartment syndrome (ACS), and this condition could lead to several organ dysfunction s... Laxative suppository agent on pediatric patient with hydrocephalus on VP shunt could lead to fatal complication through ACS and acute elevated ICP pressure. Oral laxative agent should be chosen in con...

Male Child Humans Ventriculoperitoneal Shunt Laxatives +4 autres

Constipation Severity and Quality of Life among Patients with Cancer Who Received Prophylactic Laxatives: Quasi-Experimental Study.

01 10 2022

DOI: 10.31557/APJCP.2022.23.10.3473 PMID: 36308373

Prophylactic laxatives were associated with decreasing the incidence of Opioid-induced constipation among patients with cancer. This study aims to evaluate the effectiveness of early prophylactic laxa... Using a quasi-experimental design with 64 patients assigned to control group and 66 patients assigned to intervention group. The final sample was composed from 112 patients (57 in control group and 55... Patients in the intervention group have reported a significant reduction in the severity of constipation symptoms at eight weeks post the intervention (p < 0.001). Furthermore, the patients in the int... Patients with cancer need to use the first line of laxatives as prophylactic alongside with opioids to minimize the severity of Opioid-induced constipation symptoms and to enhance the QoL....

Humans Laxatives Constipation Quality of Life Analgesics, Opioid +2 autres

Boraginaceae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Amsinckia

Borago

Consoude

Cordia

Echium

Eriodictyon

Heliotropium

Lithospermum

Pulmonaria

Auteurs principaux

Sources (114 au total)